News
Novartis After Sandoz: The Business Without Generics (NYSE:NVS)
This article was written byFollowMy professional background spans multiple continents and includes experience in private banking, corporate finance, and strategic…
SCHD: A Strong Buy After The Rebalancing (NYSEARCA:SCHD)
This article was written byFollowA financial researcher and avid investor with a keen eye for innovation and disruption, as well…
Disney Stock: How ESPN Can Be A Game-Changer (Upgrade To Strong Buy) (NYSE:DIS)
This article was written byFollowI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden YARP…
Gold Royalty Stocks To Watch: Unpacking Vox Royalty’s Potential (NASDAQ:VOXR)
This article was written byFollowLaurentian Research is a resource industry veteran with a Ph.D. in geoscience and decades of investment…
Bitcoin Decouples From The S&P 500, What This Means For Market (NYSEARCA:SPY)
This article was written byFollowMy main area of interest is algorithmic trading and trading strategies. However, I am also very…
Yield Hunting Part 18: Horizon Technology And 8.5%+ From Its Baby Bonds (NASDAQ:HRZN)
This article was written byFollowArbitrage Trader, aka Denislav Iliev has been day trading for 15+ years and leads a team…
Portfolio Rebalancing: Free Lunch Or Empty Calories? (NYSEARCA:ELM)
This article was written byFollowVictor Haghani has spent 30 years actively involved in markets and financial innovation. He started his…
CII: Looking Like A Tempting Opportunity (NYSE:CII)
This article was written byFollowNick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds…